Renaissance Capital logo

CARGO Therapeutics Priced, Nasdaq: CRGX

Phase 2 biotech developing CAR-T cell therapies for hematological cancers.

Industry: Health Care

Latest Trade: $20.05 0.00 (0.0%)

First Day Return: -3.1%

Return from IPO: +33.7%

Industry: Health Care

We are a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients. Our programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is a protein that has been engineered to modify T cells so they can recognize and destroy cancer cells. We believe the limitations of approved therapies include limited durability of effect, safety concerns and unreliable supply. Our lead program, CRG-022, an autologous (derived from a patient’s cells) CD22 CAR T-cell product candidate, the underlying CAR of which we exclusively licensed from the National Cancer Institute (NCI), is being studied by Stanford University (Stanford) in a Phase 1 clinical trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy. On the basis of the results from the clinical trial, we are evaluating CRG-022 in a potentially pivotal Phase 2 clinical trial in patients with LBCL whose disease is R/R to CD19 CAR T-cell therapy. We also plan to evaluate CRG-022 in patients at earlier stages of disease, including LBCL and other hematologic malignancies.
more less
IPO Data
IPO File Date 10/20/2023
Offer Price $15.00
Price Range $15.00 - $17.00
Offer Shares (mm) 18.8
Deal Size ($mm) $281
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/09/2023
Offer Price $15.00
Price Range $15.00 - $17.00
Offer Shares (mm) 18.8
Deal Size ($mm) $281
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
J.P. Morgan
Jefferies
more
Company Data
Headquarters San Mateo, CA, United States
Founded 2019
Employees 74
Website www.cargo-tx.com

CARGO Therapeutics (CRGX) Performance